We are live on ! Find out more
CIA

Cascade Investment Advisors Portfolio holdings

AUM $183M
1-Year Est. Return 29.64%
This Fund
S&P 500
This Quarter Est. Return
-14.26%
1 Year Est. Return
+29.64%
3 Year Est. Return
+71.4%
5 Year Est. Return
+90.78%
10 Year Est. Return
AUM
$98.9M
AUM Growth
-$19.3M
Cap. Flow
-$1.1M
Cap. Flow %
-1.11%
Top 10 Hldgs %
22.85%
Holding
239
New
42
Increased
59
Reduced
49
Closed
12

Top Buys

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$948K
2
CBRL icon
Cracker Barrel
CBRL
+$846K
3
BMY icon
Bristol-Myers Squibb
BMY
+$786K
4
ACA icon
Arcosa
ACA
+$288K
5
OVV icon
Ovintiv
OVV
+$265K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.17M
2
GSK icon
GSK
GSK
+$1.09M
3
APOG icon
Apogee Enterprises
APOG
+$962K
4
HBI
Hanesbrands
HBI
+$891K
5
VYX icon
NCR Voyix
VYX
+$783K

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Consumer Discretionary 12.82%
3 Financials 12.43%
4 Industrials 11.67%
5 Healthcare 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
1
Wells Fargo
WFC
$261B
$4.08M 4.13%
81,434
+25
+0% +$1.28K
INTC icon
2
Intel
INTC
$455B
$3.16M 3.2%
67,365
+375
+0.6% +$17.6K
USB icon
3
US Bancorp
USB
$98.2B
$2.55M 2.58%
55,860
+650
+1% +$33.5K
MSFT icon
4
Microsoft
MSFT
$3.45T
$2.37M 2.4%
23,322
+275
+1% +$29.5K
CSCO icon
5
Cisco
CSCO
$457B
$1.92M 1.94%
44,369
-125
-0.3% -$5.72K
AAPL icon
6
Apple
AAPL
$4.54T
$1.92M 1.94%
48,572
+3,340
+7% +$162K
NVS icon
7
Novartis
NVS
$297B
$1.89M 1.91%
24,558
-156
-0.6% -$12.1K
SBUX icon
8
Starbucks
SBUX
$120B
$1.6M 1.61%
24,778
-1,585
-6% -$99.2K
WELL icon
9
Welltower
WELL
$169B
$1.58M 1.6%
22,750
-260
-1% -$17.7K
OMC icon
10
Omnicom Group
OMC
$21.6B
$1.53M 1.55%
20,879
-545
-3% -$40.4K
NTR icon
11
Nutrien
NTR
$33.2B
$1.52M 1.54%
32,406
-583
-2% -$30.4K
COP icon
12
ConocoPhillips
COP
$147B
$1.47M 1.48%
23,530
+25
+0.1% +$1.7K
KR icon
13
Kroger
KR
$35.4B
$1.43M 1.45%
51,955
+750
+1% +$21.8K
INFY icon
14
Infosys
INFY
$48.7B
$1.4M 1.41%
146,850
-950
-0.6% -$9.07K
AMGN icon
15
Amgen
AMGN
$208B
$1.37M 1.38%
7,025
+175
+3% +$34.1K
DIS icon
16
Walt Disney
DIS
$167B
$1.37M 1.38%
12,470
+150
+1% +$17.1K
JWN
17
DELISTED
Nordstrom
JWN
$1.35M 1.37%
29,029
+695
+2% +$39.2K
TGT icon
18
Target
TGT
$65.6B
$1.34M 1.35%
20,230
+25
+0.1% +$1.92K
GILD icon
19
Gilead Sciences
GILD
$162B
$1.33M 1.34%
21,250
-250
-1% -$17.5K
MET icon
20
MetLife
MET
$61.9B
$1.3M 1.32%
31,673
+1,660
+6% +$71.2K
WSM icon
21
Williams-Sonoma
WSM
$26.9B
$1.28M 1.3%
50,850
HON icon
22
Honeywell
HON
$77B
$1.27M 1.29%
10,217
-482
-5% -$65.8K
SJM icon
23
J.M. Smucker
SJM
$12.7B
$1.26M 1.27%
13,454
+820
+6% +$85.6K
SABR icon
24
Sabre
SABR
$731M
$1.25M 1.27%
57,865
-325
-0.6% -$7.87K
QCOM icon
25
Qualcomm
QCOM
$155B
$1.22M 1.23%
21,425
+55
+0.3% +$3.34K

Similar funds

Cascade Investment Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Cascade Investment Advisors held 239 positions worth $98.9M, down 16% from $118M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Cascade Investment Advisors's Q4 2018 filing shows 42 new, 59 increased, 49 reduced and 12 closed positions. Its largest new stake was T. Rowe Price: 9,770 shares worth $902K. The largest sale was IBM, an estimated $1.17M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Cascade Investment Advisors's largest Q4 2018 buy was T. Rowe Price: 9,770 shares worth $902K.
  • Cascade Investment Advisors added most to Bristol-Myers Squibb in Q4 2018, an estimated $786K increase.
  • Cascade Investment Advisors's biggest Q4 2018 reduction was IBM, cutting an estimated $1.17M.
  • Cascade Investment Advisors fully exited Apogee Enterprises in Q4 2018, selling an estimated $962K.
  • Cascade Investment Advisors's ten largest holdings make up 23% of its $98.9M portfolio in Q4 2018.
  • Cascade Investment Advisors opened 42 new positions and closed 12 in Q4 2018.
  • Cascade Investment Advisors's portfolio value fell 16% quarter-over-quarter to $98.9M.

Based on Cascade Investment Advisors's 13F filing for Q4 2018, filed 25 Jan 2019.